Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -289668.18% is 43923% below its 5-year average of -658.00%, near the low end of its 5-year range (-289668.18%–10479.58%).
561.83% below its 12-month average of -43767.47%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -85229.41%.
OPERATING MARGIN
-289668.18%
OPERATING MARGIN AVG TTM
-43767.47%
OPERATING MARGIN AVG 3Y
-1882.72%
OPERATING MARGIN AVG 5Y
-658.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-561.83%
CURRENT VS 3Y AVG
-15285.63%
CURRENT VS 5Y AVG
-43922.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Senti Biosciences, Inc.
Market Cap
$10.25M
Operating Margin
-289668.18%
TTM Avg
-43767.47%
3Y Avg
-1882.72%
5Y Avg
-658.00%
Market Cap
$10.47M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.41M
Operating Margin
N/A
TTM Avg
-2960.13%
3Y Avg
-1713.73%
5Y Avg
-1142.49%
Market Cap
$10.22M
Operating Margin
0.00%
TTM Avg
-390.79%
3Y Avg
-392.52%
5Y Avg
-325.49%
Market Cap
$10.11M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.10M
Operating Margin
-76.66%
TTM Avg
-76.42%
3Y Avg
-167.47%
5Y Avg
-192.55%
Market Cap
$10.90M
Operating Margin
-2455.91%
TTM Avg
-2057.20%
3Y Avg
-5101.18%
5Y Avg
-6363.25%
Market Cap
$10.91M
Operating Margin
-140807.24%
TTM Avg
-140807.24%
3Y Avg
-140807.24%
5Y Avg
-140807.24%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Senti Biosciences, Inc. (SNTI) | $10.25M | -289668.18% | -43767.47% | -1882.72% | -658.00% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.47M | 0.00% | 0.00% | 0.00% | 0.00% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.41M | N/A | -2960.13% | -1713.73% | -1142.49% |
| Polyrizon Ltd. (PLRZ)vs › | $10.42M | N/A | 0.00% | 0.00% | 0.00% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.22M | 0.00% | -390.79% | -392.52% | -325.49% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lifeward Ltd. (LFWD)vs › | $10.10M | -76.66% | -76.42% | -167.47% | -192.55% |
| Pluri Inc. (PLUR)vs › | $10.90M | -2455.91% | -2057.20% | -5101.18% | -6363.25% |
| Caring Brands, Inc. (CABR)vs › | $10.91M | -140807.24% | -140807.24% | -140807.24% | -140807.24% |
| MetaVia Inc. (MTVA)vs › | $9.82M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
-16431.8%
Operating Margin
-289668.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -85229.41% |
| 2026-03-31 | -71862.50% |
| 2025-12-31 | -61745.45% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | -17206.27% |
| 2023-06-30 | -1620.92% |
| 2023-03-31 | -1163.61% |
| 2022-12-31 | 10479.58% |
| 2022-09-30 | -972.82% |
| 2022-06-30 | -1964.89% |
| 2022-03-31 | -1065.04% |
| 2021-12-31 | -1372.64% |
| 2021-09-30 | -1233.59% |
| 2021-06-30 | -1134.43% |
| 2021-03-31 | -12697.22% |
| 2020-12-31 | -327400.00% |
